Shreyas Intermediates Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 20, 2026

Key Highlights

The Latest Trading Price of Shreyas Intermediates Ltd is ₹ 6.6 as of 20 Mar 15:30 . The P/E Ratio of Shreyas Intermediates Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Shreyas Intermediates Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Shreyas Intermediates Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Shreyas Intermediates Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Shreyas Intermediates Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Shreyas Intermediates Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Shreyas Intermediates Ltd

Shreyas Intermediates Limited (SIL) was incorporated as a Private Limited Company on November 6, 1989 and subsequently converted into a Public Limited Company in April, 1992.
The Company was promoted by Dinesh S Sharma.
The Company is engaged in manufacturing of Dyes, Pigments and Pigment Intermediates. In Dec.'93, the company came out with its initial public offering, aggregating Rs 3.29 Cr, to diversify into the manufacture of Copper Phthalocyanine Blue Crude and Copper Phthalocyanine Green, with a capacity of 540 TPA and 321 TPA respectively.
The estimated cost of the project was Rs 8.60 Cr.
Both the products have good export potential especially in the US and Germany. The products of SIL find application in the manufacture of plastic colours, direct colours, inks, rubber paints and in the paint industry.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Shreyas Intermediates Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Shreyas Intermediates Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Shreyas Intermediates Ltd is 46 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr

What are the key factors driving the stock performance of Shreyas Intermediates Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Shreyas Intermediates Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shreyas Intermediates Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 20, 2026, the Shreyas Intermediates Ltd stock price is INR ₹6.6. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45.

How do dividend payouts of Shreyas Intermediates Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Shreyas Intermediates Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.